The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Multiple sclerosis and depression
Abstract
Clinically significant depression can affect up to 50% of patients with multiple sclerosis over the course of their lifetime. It is associated with an increased morbidity and mortality and is regarded by patients as one of the main determinants of their quality of life. This review summarizes current perspectives relating to diagnosis, the utility of self report screening questionnaires, warning signs of suicidal intent and the biological and psychosocial variables implicated in mood change. In particular, the association between depression and structural brain abnormalities, including those derived from diffusion tensor imaging, is highlighted. Depression is treatable, as the results from randomized controlled trials of antidepressant medication, cognitive behavior therapy and mindfulness therapy, reveal. These positive findings are offset by data showing that depression in a neurological setting is often overlooked and under treated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and is three times higher than in the general population [4].”
In the citing paper
“Mindfulness can positively have an effect on coping strategies and on the adaptation to the disease, by encouraging patients to relate differently to their physical and psychological symptoms [4].”
In the citing paper
“In particular, depression seems to be more prevalent in MS than in other chronic neurological diseases (Wallin et al., 2006) and three times more prevalent than in the general population (Feinstein, 2011).”
From The effectiveness of a body-affective mindfulness intervention for multiple sclerosis patients with depressive symptoms: A randomized controlled clinical trial (2017) · cites this paper as Feinstein, 2011
In the citing paper
“Mindfulness can lead patients to relate to their physical and psychological symptoms in a different way, with a positive effect on coping strategies and adaptation to the disease (Feinstein, 2011).”
From The effectiveness of a body-affective mindfulness intervention for multiple sclerosis patients with depressive symptoms: A randomized controlled clinical trial (2017) · cites this paper as Feinstein, 2011
In the citing paper
“In MS depression is one of the main determinants of patients’ quality of life.”
From The effectiveness of a body-affective mindfulness intervention for multiple sclerosis patients with depressive symptoms: A randomized controlled clinical trial (2017) · cites this paper as Feinstein, 2011
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
The IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.655 · Cited by 2,085
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J., Swartz, E., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 532
Major depression in multiple sclerosis: A population-based perspective
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095964.34294.b4 · Cited by 529
Validation of the Hospital anxiety and depression scale for use with multiple sclerosis patients
Honarmand, K., & Feinstein, A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509347150 · Cited by 436 · cited 1×
“Examples of these are the Hospital Anxiety andDepression Scale and the BeckFast Screen for depression in medically ill patients, both of which have been validated for patients with multiple sclerosis.(12,13) Useful as they are for screening purposes and clinical trials, self-report questionnaires cannot generate a dia…”
MethodSelf-citationAffective Disorders in Multiple Sclerosis Review and Recommendations for Clinical Research
Minden, S. L., & Schiffer, R. B. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010124031 · Cited by 419
MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial
Grossman, P., Kappos, L., Gensicke, H., D'Souza, M., Mohr, D. C., Penner, I. K., & Steiner, C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f4d80d · Cited by 419 · cited 1×
“In an eight week randomized, placebo controlled trial of 67 patients, MBI proved more effective than care as usual in improving health related quality of life, depression, anxiety and fatigue.(46) As with CBT, mindfulness based interventions cannot be used in patients with significant cognitive compromise.”
Cause of death in patients attending multiple sclerosis clinics
Sadovnick, A. D., Eisen, K., Ebers, G. C., & Paty, D. W. (1991) · Neurology · doi:10.1212/wnl.41.8.1193 · Cited by 401
Benedict, R. H. B., Weinstock-Guttman, B., Fishman, I., Sharma, J., Tjoa, C. W., & Bakshi, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.2.226 · Cited by 367
Research works printed but not linked: 5
- 10.1037/0894-4105.13.3.434 · doi:10.1037/0894-4105.13.3.434 · Paper page
- Gold SM, Biol Psychiatry
- Kiy G, Mult Scler
- 10.1037/0278-6133.18.4.383 · doi:10.1037/0278-6133.18.4.383 · Paper page
- Koch MW, 2011, Cochrane Datab Syst Rev, 16, CD007295
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis
Boeschoten, R. E., Braamse, A. M. J., Beekman, A. T. F., Cuijpers, P., van Oppen, P., Dekker, J., & Uitdehaag, B. M. J. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.067 · Cited by 713
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
Rocca, M. A., Amato, M. P., De Stefano, N., Enzinger, C., Geurts, J. J., Penner, I.-K., Rovira, A., Sumowski, J. F., Valsasina, P., & Filippi, M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70250-9 · Cited by 557
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564487 · Cited by 519
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Wingerchuk, D. M., & Carter, J. L. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.11.002 · Cited by 416
Metadata
- Authors
- Feinstein, A.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Feinstein, Anthony
- ORCID
- Feinstein, Anthony
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2011-11
- Volume
- 17
- Issue
- 11
- Pages
- 1276-1281
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2114080475
- Cited by
- 337
- References
- 50
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 13 · 2023: 25 · 2022: 14 · 2021: 12 · 2020: 22 · 2019: 20 · 2018: 34 · 2017: 26 · 2016: 30 · 2015: 34 · 2014: 39 · 2013: 30 · 2012: 11
- FWCI
- 18.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- multiple sclerosis, depression, quality of life, suicide risk, structural brain abnormalities, diffusion tensor imaging, antidepressant treatment, cognitive behavioral therapy, mindfulness therapy, underdiagnosis and undertreatment
- MeSH terms
- Suicide Prevention, Affect, Depression, Humans, Multiple Sclerosis, Prognosis, Psychiatric Status Rating Scales, Quality of Life, Surveys and Questionnaires, Risk Factors, Suicide, Prevalence, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple sclerosis and depression. https://app.cochat.ai/papers/10.1177/1352458511417835
- The paper
- Feinstein, A. (2011). Multiple sclerosis and depression. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458511417835
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.